重組蛋白
重組蛋白質(zhì)是分析生物相互作用的有用工具。在研究實驗室中使用了大量的重組蛋白質(zhì),包括商業(yè)蛋白質(zhì)和在特定研究項目中生成的蛋白質(zhì)。它們在許多應(yīng)用中發(fā)揮著關(guān)鍵作用。
如果您正在尋找具有優(yōu)良質(zhì)量(驗證的生物活性,較低的內(nèi)毒素水平和高純度)的重組蛋白質(zhì)來支持您的研究,您來對地方了。
經(jīng)過16多年的發(fā)展,華美生物已經(jīng)建立了從原核到真核的五大系統(tǒng),用于表達重組蛋白質(zhì)。我們擁有一系列蛋白質(zhì)表達和純化技術(shù),包括基于桿狀病毒外膜蛋白(OMP)的蛋白質(zhì)表達技術(shù),以及膜蛋白表達技術(shù)等。
產(chǎn)品特點
- 超過10,000種重組蛋白覆蓋大多數(shù)基因/靶點;
- 5種表達系統(tǒng),包括大腸桿菌(E.coli)、酵母、桿狀病毒感染的昆蟲細胞、哺乳動物細胞和體外大腸桿菌。而體外大腸桿菌表達系統(tǒng)是華美生物的獨特表達系統(tǒng)。與傳統(tǒng)蛋白表達系統(tǒng)相比,體外大腸桿菌省略了許多過程,如質(zhì)粒轉(zhuǎn)化、細胞培養(yǎng)、收集、破碎和離心等,大大提高了工作效率。
- 多種標簽,包括His、GST、Flag、MBP等。
- 廣泛應(yīng)用,包括抗原、細胞分析、結(jié)合分析/蛋白質(zhì)相互作用、細胞培養(yǎng)-無血清培養(yǎng)基、藥物相關(guān)研究、體外酶活性、ELISA標準及其原料、體內(nèi)研究、質(zhì)譜標準、蛋白芯片、SDS-PAGE控制、蛋白質(zhì)結(jié)構(gòu)分析(晶體/電子顯微鏡)。
- 多種物種,包括人類、小鼠、大鼠、兔子、豚鼠、雞、猴子、豬等。
- 無動物副產(chǎn)品的動物源性重組蛋白質(zhì)。華美生物已開發(fā)出無動物副產(chǎn)品接觸的重組蛋白質(zhì)產(chǎn)品線。
重組蛋白目錄
以下是所有重組蛋白的目錄。您可以在目錄中找到適合您研究的蛋白質(zhì),或在本網(wǎng)站頭部的搜索框中搜索它們。
如果您找不到您需要的抗體,請查看華美生物蛋白質(zhì)定制服務(wù)。
通過選擇目標名稱的首字母瀏覽產(chǎn)品。
產(chǎn)品名稱 | 貨號 | 規(guī)格 |
---|---|---|
Recombinant Ashbya gossypii Protein HIR2 (HIR2), partial | CSB-YP748404DOT CSB-EP748404DOT CSB-BP748404DOT CSB-MP748404DOT CSB-EP748404DOT-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Ashbya gossypii Protein FYV8 (FYV8), partial | CSB-YP748405DOT CSB-EP748405DOT CSB-BP748405DOT CSB-MP748405DOT CSB-EP748405DOT-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Ashbya gossypii Altered inheritance of mitochondria protein 34, mitochondrial (AIM34), partial | CSB-YP748406DOT CSB-EP748406DOT CSB-BP748406DOT CSB-MP748406DOT CSB-EP748406DOT-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Ashbya gossypii COP9 signalosome complex subunit 11 (PCI8) | CSB-YP748407DOT CSB-EP748407DOT CSB-BP748407DOT CSB-MP748407DOT CSB-EP748407DOT-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Ashbya gossypii Ubiquitin-like-conjugating enzyme ATG10 (ATG10) | CSB-YP748408DOT CSB-EP748408DOT CSB-BP748408DOT CSB-MP748408DOT CSB-EP748408DOT-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Ashbya gossypii Translation machinery-associated protein 22 (TMA22) | CSB-YP748409DOT CSB-EP748409DOT CSB-BP748409DOT CSB-MP748409DOT CSB-EP748409DOT-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Ashbya gossypii Mitochondrial import inner membrane translocase subunit TIM21 (TIM21), partial | CSB-YP748410DOT CSB-EP748410DOT CSB-BP748410DOT CSB-MP748410DOT CSB-EP748410DOT-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Ashbya gossypii Altered inheritance of mitochondria protein 11 (AIM11), partial | CSB-YP748411DOT1 CSB-EP748411DOT1 CSB-BP748411DOT1 CSB-MP748411DOT1 CSB-EP748411DOT1-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Ashbya gossypii Phosphatidylinositol N-acetylglucosaminyltransferase ERI1 subunit (ERI1), partial | CSB-YP748412DOT1 CSB-EP748412DOT1 CSB-BP748412DOT1 CSB-MP748412DOT1 CSB-EP748412DOT1-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Ashbya gossypii Serine/threonine-protein phosphatase 4 regulatory subunit 2 (PSY4) | CSB-YP748413DOT CSB-EP748413DOT CSB-BP748413DOT CSB-MP748413DOT CSB-EP748413DOT-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Ashbya gossypii Serine/threonine-protein kinase MEC1 (MEC1), partial | CSB-YP748414DOT CSB-EP748414DOT CSB-BP748414DOT CSB-MP748414DOT CSB-EP748414DOT-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Ashbya gossypii Biogenesis of lysosome-related organelles complex 1 subunit BLI1 (BLI1) | CSB-YP748415DOT CSB-EP748415DOT CSB-BP748415DOT CSB-MP748415DOT CSB-EP748415DOT-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Ashbya gossypii Maintenance of telomere capping protein 2 (MTC2) | CSB-YP748416DOT CSB-EP748416DOT CSB-BP748416DOT CSB-MP748416DOT CSB-EP748416DOT-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Ashbya gossypii Eukaryotic translation initiation factor 3 subunit A (TIF32), partial | CSB-YP748417DOT CSB-EP748417DOT CSB-BP748417DOT CSB-MP748417DOT CSB-EP748417DOT-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Ashbya gossypii Homoaconitase, mitochondrial (LYS4), partial | CSB-YP748418DOT CSB-EP748418DOT CSB-BP748418DOT CSB-MP748418DOT CSB-EP748418DOT-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Ashbya gossypii Serine/threonine-protein phosphatase 4 regulatory subunit 3 (PSY2), partial | CSB-YP748419DOT CSB-EP748419DOT CSB-BP748419DOT CSB-MP748419DOT CSB-EP748419DOT-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Ashbya gossypii Probable cysteine protease ATG4 (ATG4), partial | CSB-YP748420DOT CSB-EP748420DOT CSB-BP748420DOT CSB-MP748420DOT CSB-EP748420DOT-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Ashbya gossypii DNA replication complex GINS protein PSF1 (PSF1) | CSB-YP748421DOT CSB-EP748421DOT CSB-BP748421DOT CSB-MP748421DOT CSB-EP748421DOT-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Ashbya gossypii Protein SDS23 (SDS23) | CSB-YP748422DOT CSB-EP748422DOT CSB-BP748422DOT CSB-MP748422DOT CSB-EP748422DOT-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
Recombinant Ashbya gossypii Methylthioribose-1-phosphate isomerase (MRI1) | CSB-YP748423DOT CSB-EP748423DOT CSB-BP748423DOT CSB-MP748423DOT CSB-EP748423DOT-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
引用資料
Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023
Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023
Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023
Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023
Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022